Laser Photonics Corporation reports developments tied to photonics-based industrial and defense laser systems. The company develops and manufactures laser technologies for cleaning, surface preparation, corrosion removal, de-coating, pre- and post-welding applications, and precision material processing across defense and government, aerospace, energy, maritime, automotive, and advanced manufacturing markets.
Recurring LASE news includes DefenseTech laser cleaning deployments, Laser Shield Anti-Drone System development, product validation with affiliated LASE Group companies, operating and financial results, facility and portfolio consolidation, warrant exercises and other capital-structure actions, and Nasdaq listing-compliance matters.
Laser Photonics (NASDAQ:LASE) will change its corporate name to LASE Corp. effective November 4, 2026, as part of a rebranding. The company said it is prioritizing defense growth while continuing to develop its pharmaceutical, semiconductor and industrial businesses.
The corporate website, www.lase.com, will house investor relations. Phased website relaunches are planned over the next several weeks, assigning Beamer Laser to industrial markets, Laser Photonics to semiconductor and quantum computing, CMS Laser to pharmaceutical and medical markets, and Fonon Technologies to defense and security. The company also plans to introduce its Quantum Bullet anti-drone laser platform at I/ITSEC in Orlando, November 30–December 3, 2026.
Laser Photonics (LASE) announced plans to launch its Quantum Bullet anti-drone platform at the I/ITSEC military modeling, simulation and training conference. The event runs November 30 through December 3, 2026, in Orlando, Florida.
The product line includes the Laser Shield Anti-Drone series, which the company is developing as a modular platform combining laser capabilities with detection, tracking and command-and-control systems. Planned configurations include a Dazzler intended to interfere with drone optical sensors and higher-energy laser and crawler configurations intended to destroy drones.
Laser Photonics (NASDAQ:LASE) will release its third-quarter 2026 financial results before market open on November 12, 2026. Management will host an earnings call at 8:00 a.m. Eastern time that day to discuss results for the quarter ended September 30, 2026, provide a corporate update and answer questions from telephone participants.
A telephone replay will be available through November 19, 2026, and a webcast replay will also be available.
Laser Photonics (NASDAQ:LASE) appointed Tim Peterman as chief financial officer as part of its financial management and governance efforts. Peterman brings more than three decades of experience in public-company capital markets, financial operations, SEC compliance and mergers and acquisitions.
The company also recently engaged Sheppard, Mullin, Richter & Hampton as outside securities counsel and CBIZ for external financial reporting consulting. Sheppard will advise on securities law, reporting obligations, governance and capital markets. CBIZ will support financial reporting processes and internal control practices. The company said these steps support its efforts to establish financial accountability and prepare for growth.
Laser Photonics (NASDAQ:LASE) appointed founder Dmitri Nikitin Executive Chairman and principal executive officer, with authority and responsibilities customarily associated with a CEO.
He succeeds Wayne Tupuola in the principal executive officer role following Tupuola's resignation as CEO for medical reasons, effective October 13, 2026. The company does not currently intend to appoint a separate CEO. Ann Tewari's interim presidency also concluded October 13; she returned to her previous role as Global Vice President, Operations and Strategy.
Nikitin's initial priorities include advancing the Laser Shield Anti-Drone platform, strengthening engineering, developing a disciplined marketing and sales organization, and integrating previous acquisitions and multiple product lines into one organization.
Laser Photonics (LASE) closed a public offering on September 14, 2026, raising approximately $7.9 million in gross proceeds.
The offering consisted of 10,500,000 shares of common stock, Series B-1 warrants to purchase up to 10,500,000 shares, and Series B-2 warrants to purchase up to 10,500,000 shares, all sold at a combined public offering price of $0.75 per share and accompanying warrants. Both warrant series carry an exercise price of $0.75 per share and are exercisable upon issuance, with the Series B-1 warrants expiring five years from issuance and the Series B-2 warrants expiring twenty-four months from issuance. H.C. Wainwright & Co. acted as exclusive placement agent.
The company plans to use net proceeds for research and development of its laser-based technologies, acquisitions, and working capital. The securities were offered under an effective Form S-1 registration statement.
Laser Photonics (LASE) priced a public offering of 10,500,000 common shares together with Series B-1 and Series B-2 warrants, for expected gross proceeds of approximately $7.9 million at a combined public offering price of $0.75 per share and accompanying warrants.
Investors will receive one Series B-1 warrant and one Series B-2 warrant for each share, each exercisable at $0.75 per share upon issuance. The Series B-1 warrants will expire five years from issuance, and the Series B-2 warrants will expire twenty-four months from issuance. Closing is expected on or about September 14, 2026, subject to customary conditions.
The company plans to use net proceeds for research and development of its laser-based technologies, acquisitions, and working capital. H.C. Wainwright & Co. is acting as exclusive placement agent, and the offering is being made under an effective Form S-1 registration statement.
Laser Photonics (LASE) received a repeat purchase order from an established Canadian manufacturer for a Beamer B-Series FB23 laser marking system and a fume extraction unit. The buyer is a long-time Beamer user upgrading from an earlier-generation system that has been in production for over a decade.
The B-Series FB23 features a 20-watt fiber laser, compact footprint, and capacity for parts up to 13.5 inches tall. Its modular, automation-ready design supports options such as autofocus, automated doors, rotary systems, and machine vision, allowing customers to adapt the platform as production needs evolve.
Laser Photonics (NASDAQ: LASE) and affiliated Fonon Technologies reported continued advancement of the Laser Shield Anti-Drone (LSAD) system following a direct engagement with U.S. Special Operations Command (SOCOM). The meeting allowed the LASE Group to present LSAD’s directed-energy counter‑UAS capabilities and discuss its potential role against Group 1 and Group 2 small drones.
According to Laser Photonics, LSAD is being developed as a modular, standalone perimeter‑defense architecture integrating detection, tracking, identification, decision support and laser engagement for fixed, palletized, vehicle‑mounted, soldier‑portable and unmanned configurations. Live testing at Lake Mary, Florida showed LSAD autonomously detect, track and neutralize a simulated Class I drone decoy in under three seconds, building on earlier trials where detection software tracked target drones in over 95% of real‑world scenarios. The company states these results support ongoing U.S. government evaluations, including the U.S. Air Force Shaw AFB Battle Lab CSO process and the Department of War’s MEIA Vulcan Call for Solutions.
Laser Photonics (NASDAQ:LASE) announced that subsidiary CMS Laser received a purchase order of approximately $1.05 million from a U.S.-based pharmaceutical company for a TD-70 high-speed tablet drilling system, marking a first-time purchase and entry into a new pharmaceutical manufacturing account.
The order covers a complete production line, including tablet handling tooling, conveyor transport, full IQ/OQ/PQ validation package, and on-site installation from CMS engineers. The TD-70 offers throughput up to 70,000 tablets per hour and a dual-camera vision system that inspects each tablet twice. According to Laser Photonics, the system will be built at CMS Laser’s Winter Park, Florida facility, and the company plans to increase investment in CMS Laser’s technology platform to support growth across pharmaceutical, medical device, and other regulated end markets.